CN102497860A - 病毒感染的治疗 - Google Patents

病毒感染的治疗 Download PDF

Info

Publication number
CN102497860A
CN102497860A CN2010800404927A CN201080040492A CN102497860A CN 102497860 A CN102497860 A CN 102497860A CN 2010800404927 A CN2010800404927 A CN 2010800404927A CN 201080040492 A CN201080040492 A CN 201080040492A CN 102497860 A CN102497860 A CN 102497860A
Authority
CN
China
Prior art keywords
chemical compound
amino
chlorphenyl
virus
aforementioned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800404927A
Other languages
English (en)
Chinese (zh)
Inventor
约翰·布鲁
罗宾·马克·班尼斯特
格里戈里·艾伦·斯托洛夫
威尔逊·卡帕罗斯·万德莱
奥尔加·普莱格苏埃洛斯马泰奥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocopea Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0913914A external-priority patent/GB0913914D0/en
Priority claimed from GBGB1001821.6A external-priority patent/GB201001821D0/en
Priority claimed from GB1012168A external-priority patent/GB2477584A/en
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of CN102497860A publication Critical patent/CN102497860A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2010800404927A 2009-08-10 2010-08-10 病毒感染的治疗 Pending CN102497860A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0913914A GB0913914D0 (en) 2009-08-10 2009-08-10 Treatment of viral infections
GB0913914.8 2009-08-10
GBGB1001821.6A GB201001821D0 (en) 2010-02-04 2010-02-04 Treatment of viral infections
GB1001821.6 2010-02-04
GB1012168.9 2010-07-20
GB1012168A GB2477584A (en) 2010-02-04 2010-07-20 A compound for use in treating an acute viral infection
PCT/GB2010/051317 WO2011018653A2 (en) 2009-08-10 2010-08-10 Treatment of viral infections

Publications (1)

Publication Number Publication Date
CN102497860A true CN102497860A (zh) 2012-06-13

Family

ID=43063293

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800404927A Pending CN102497860A (zh) 2009-08-10 2010-08-10 病毒感染的治疗

Country Status (9)

Country Link
US (1) US20120283334A1 (enExample)
EP (1) EP2464345A2 (enExample)
JP (1) JP2013501770A (enExample)
CN (1) CN102497860A (enExample)
AU (1) AU2010283583A1 (enExample)
IN (1) IN2012DN02123A (enExample)
RU (1) RU2012108048A (enExample)
SG (1) SG178345A1 (enExample)
WO (1) WO2011018653A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108721262A (zh) * 2017-04-13 2018-11-02 中国科学院武汉病毒研究所 安非他酮在制备治疗或预防流感病毒感染的药物中的应用
CN115068453A (zh) * 2021-03-15 2022-09-20 中国医学科学院药物研究所 沙美特罗防治流感的药物用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033827A1 (en) * 1998-12-08 2000-06-15 Planisphere Corp. Bupropion to treat viral diseases
DE102004063132A1 (de) * 2004-12-22 2006-07-06 Schmiegel, Wolff, Prof. Dr. Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060173080A1 (en) * 2002-09-14 2006-08-03 The Regents Of The University Of California Methods of modulating TNF using bupropion

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033827A1 (en) * 1998-12-08 2000-06-15 Planisphere Corp. Bupropion to treat viral diseases
DE102004063132A1 (de) * 2004-12-22 2006-07-06 Schmiegel, Wolff, Prof. Dr. Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MYLES MARVIN E ET AL: "Bupropion(Zyban,Wellbutrin) inhibits nicotine-induced viral reactivation in herpes simplex virus type 1 latent rabbits", 《JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108721262A (zh) * 2017-04-13 2018-11-02 中国科学院武汉病毒研究所 安非他酮在制备治疗或预防流感病毒感染的药物中的应用
CN115068453A (zh) * 2021-03-15 2022-09-20 中国医学科学院药物研究所 沙美特罗防治流感的药物用途

Also Published As

Publication number Publication date
EP2464345A2 (en) 2012-06-20
IN2012DN02123A (enExample) 2015-08-21
WO2011018653A2 (en) 2011-02-17
SG178345A1 (en) 2012-03-29
WO2011018653A3 (en) 2011-04-07
JP2013501770A (ja) 2013-01-17
RU2012108048A (ru) 2013-09-20
AU2010283583A1 (en) 2012-03-08
US20120283334A1 (en) 2012-11-08

Similar Documents

Publication Publication Date Title
JP5380078B2 (ja) アレナウイルス感染の治療のための抗ウイルス薬剤
KR101706624B1 (ko) 고병원성 감염성 질환의 예방 및 치료제
EA037529B1 (ru) Способ получения соединения для ингибирования репликации вирусов гриппа
CN103648491B (zh) 用于抑制流感病毒复制的方法和药物组合物
US12630589B2 (en) Compounds for use in viral infections
JP6884112B2 (ja) インフルエンザを治療するための新規抗ウイルス性組成物
JP5937060B2 (ja) 呼吸器ウイルス感染症の治療方法
CN110603041A (zh) 用于治疗流感病毒感染的组合治疗
AU2016287580A2 (en) Compositions and methods for the treatment of viral infection
CN111420024A (zh) 杆菌酞a在制备预防和治疗冠状病毒的药物中的应用
CN102740845A (zh) 微生物感染的治疗
CN114667138A (zh) Mek抑制剂与帽状结构依赖型核酸内切酶抑制剂的组合
US20120283334A1 (en) Treatment of Viral Infections
KR20230021009A (ko) 항바이러스 치료로서의 아젤라스틴
EP4710930A1 (en) Anti-influenza virus composition containing xanthan gum or fucoidan
EP4221706B1 (en) Treatment for viral infection
GB2477584A (en) A compound for use in treating an acute viral infection
US20230114000A1 (en) Antiviral composition containing fucosyllactose as active ingredient
CN119868562B (zh) Cul4b激活剂在制备抗流感病毒药物中的应用
EP3880251B1 (en) Formulations of influenza therapeutics
CN103169970A (zh) 一种治疗病毒性肺炎的药物组合物
US20120157519A1 (en) Tellerium-containing compounds for treating viral infections
CN117838698A (zh) 奥拉替尼在制备治疗流感病毒感染的药物中的应用
CN121466087A (zh) Pha-767491在制备防治h1n1亚型猪流感药物中的应用
CN117838689A (zh) 培菲替尼在制备治疗流感病毒感染的药物中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120613